HealthDay - WEDNESDAY, Feb. 24 (HealthDay News) -- Mirapex ER (pramipexole
dihydrochloride extended-release) has been approved by the U.S. Food and
Drug regency as a once-daily option to treat early Parkinson's
disease, drug maker Boehringer Ingelheim said in a news release.

More: - Read More